Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

Rhythm AI, a UK-based company specialising in atrial fibrillation procedures, has announced that its STAR Apollo Mapping System has received 510k clearance from the US Food and Drug Administration (FDA) for use in atrial fibrillation (AF). The STAR Apollo Mapping System now has increased compatibility, which includes Johnson & Johnson’s CARTO 3 Mapping System. It […] The post Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation appeared first on Pharmafile.

Continue reading →